Ancora Advisors LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 93 filers reported holding UTAH MED PRODS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$1,432,502
-10.5%
16,657
-3.1%
0.04%
-9.5%
Q2 2023$1,601,362
-23.7%
17,182
-22.4%
0.04%
-30.0%
Q1 2023$2,098,397
+91693.4%
22,142
-2.6%
0.06%
-9.1%
Q4 2022$2,286
-99.9%
22,741
-6.2%
0.07%
+3.1%
Q3 2022$2,069,000
-0.7%
24,2490.0%0.06%
+8.5%
Q2 2022$2,083,000
-10.3%
24,249
-6.2%
0.06%
+5.4%
Q1 2022$2,322,000
-13.0%
25,839
-3.2%
0.06%
-11.1%
Q4 2021$2,669,000
-8.3%
26,689
-14.9%
0.06%
-16.0%
Q3 2021$2,912,000
+11.3%
31,362
+1.9%
0.08%
+10.3%
Q2 2021$2,616,000
-25.1%
30,765
-23.7%
0.07%
-29.2%
Q1 2021$3,494,000
+2.5%
40,338
-0.3%
0.10%
-12.7%
Q4 2020$3,409,000
+4.6%
40,448
-0.8%
0.11%
-14.7%
Q3 2020$3,258,000
-30.5%
40,788
-22.9%
0.13%
-34.2%
Q2 2020$4,686,000
-20.0%
52,873
-15.2%
0.20%
-27.7%
Q1 2020$5,861,000
-20.4%
62,319
-8.7%
0.27%
-1.1%
Q4 2019$7,366,000
+10.9%
68,266
-1.5%
0.27%
-5.5%
Q3 2019$6,641,000
-23.9%
69,288
-0.2%
0.29%
-25.8%
Q2 2019$8,726,000
+57.5%
69,417
+68.7%
0.39%
+55.8%
Q1 2019$5,542,000
-11.6%
41,141
-24.8%
0.25%
-16.9%
Q4 2018$6,272,000
-13.1%
54,683
-28.6%
0.30%
+8.6%
Q3 2018$7,217,000
-2.8%
76,621
+13.7%
0.28%
-13.7%
Q2 2018$7,423,000
-5.6%
67,387
-15.3%
0.32%
-9.0%
Q1 2018$7,867,000
+37.4%
79,587
+13.1%
0.35%
+15.7%
Q4 2017$5,727,000
+27.9%
70,358
+15.6%
0.31%
+17.7%
Q3 2017$4,478,000
+12.1%
60,881
+10.4%
0.26%
+0.4%
Q2 2017$3,993,000
+23.7%
55,159
+6.4%
0.26%
+18.3%
Q1 2017$3,229,000
-9.1%
51,829
+6.1%
0.22%
-15.4%
Q4 2016$3,553,000
+71.1%
48,845
+40.7%
0.26%
+23.3%
Q3 2016$2,076,000
+24.1%
34,717
+30.7%
0.21%
+7.7%
Q2 2016$1,673,000
+0.2%
26,562
-0.5%
0.20%
-4.9%
Q1 2016$1,669,000
-40.8%
26,690
-43.9%
0.20%
+12.0%
Q4 2015$2,820,000
+97.2%
47,614
+79.3%
0.18%
-0.5%
Q3 2015$1,430,000
-8.1%
26,552
+1.8%
0.18%
+0.5%
Q2 2015$1,556,000
+16.9%
26,0900.18%
+12.3%
Q1 2015$1,331,000
+0.7%
0
-100.0%
0.16%
+1.2%
Q4 2014$1,322,000
+23.2%
22,009
+0.0%
0.16%
+16.7%
Q3 2014$1,073,000
+30.7%
22,006
+37.9%
0.14%
+30.2%
Q2 2014$821,000
+23.6%
15,955
+39.0%
0.11%
+12.8%
Q1 2014$664,000
+2.0%
11,479
+0.8%
0.09%
-4.1%
Q4 2013$651,000
+5.5%
11,389
+9.6%
0.10%
-7.5%
Q3 2013$617,000
+114.2%
10,387
+95.8%
0.11%
+116.3%
Q2 2013$288,0005,3050.05%
Other shareholders
UTAH MED PRODS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 13,948$1,321,8521.25%
Clean Yield Group 25,683$2,433,9781.04%
RICE HALL JAMES & ASSOCIATES, LLC 114,123$10,815,4460.61%
Ranger Investment Management 72,525$6,873,1940.46%
Watershed Asset Management, L.L.C. 2,748$260,4280.32%
ISTHMUS PARTNERS, LLC 21,005$1,990,6440.28%
Cardinal Capital Management 11,166$1,061,4730.22%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 5,893$558,4800.15%
GLOBEFLEX CAPITAL L P 9,710$920,2170.11%
Penobscot Investment Management Company, Inc. 4,000$379,0800.07%
View complete list of UTAH MED PRODS INC shareholders